US biotech Incyte Pharma is nearing a deal for up to $2bn to buy privately held blood disorder drug...
Incyte nears up to $2bn deal for blood disorder biotech Star
US biotech Incyte Pharma is nearing a deal for up to $2bn to buy privately held blood disorder drug developer Star Therapeutics amid a wave of acquisitions...
Author: Financial Times
Read Original Article